Pfizer will on Wednesday place an offer in the final round of bids for German generic drug maker Rati0pharm, a person briefed on the matter told us yesterday. Israel’s Teva and smaller Icelandic peer Actavis had been requested to make final bids on Thursday at the latest, sources had previously said. Read the Reuters story here.
Australia’s Arrow Energy has opened its books to Royal Dutch Shell and PetroChina for them to conduct due diligence for their joint takeover offer worth at least $3 billion our sources tell us. Read our story here.
Bharti Airtel looks set to land its $9 billion purchase of Zain‘s African assets, overcoming a stumbling block posed by an ownership spat over Zain’s Nigerian units. A team of bankers from UBS — which is advising Zain — visited Nigeria with Bharti Chairman Sunil Mittal last week. The two parties had worked their way around the problem, sources tell us, though they did not say how. Exclusivity expires on March 25.
For all further deals news on Reuters, click here. And elsewhere in media:
San Miguel Corp plans to raise $1 billion by selling stakes in its food, packaging and liquor businesses to fund the Philippines’ biggest food and drinks maker’s growth and acquisitions, Bloomberg reports.
China’s homegrown automaker Zhejiang Geely Holding is facing financing and technology hurdles in its bid to pay up to $2 billion for Ford ‘s Volvo car unit and the likelihood of a short-term deal is low, China Daily reports.